lex Sandhu, MD, MS, assistant professor of cardiovascular medicine, Stanford University, and cardiologist at the Palo Alto VA. He spoke in the business of cardiology sessions at ACC 2024 and explained how Medicare reimbursements will be moving toward a value based payment model by 2030. #ACC #ACC24 #ACC2024 #CMS #reimbersements #Medicare

How the shift to value-based reimbursements could transform cardiology

"I think we really need our cardiologist community to understand the changes that are happening with value-based payment," one expert tells Cardiovascular Business. 

heart patient

New hypertrophic cardiomyopathy guidelines highlight importance of exercise, new drug class

HCM is widely underdiagnosed, but the American College of Cardiology and American Heart Association hope their new guidelines can help cardiologists learn more about the potentially fatal condition and improve patient care. 

HRS 2024: Late-breaking clinical trials will highlight key trends in electrophysiology

A total of 21 late-breaking science presentations are scheduled for Heart Rhythm 2024 in Boston. 

Faluso Fakorede, MD, interventional cardiologiost, explains how health disparities serve as a primary driver of 400 amputations a day because patients are not accessing healthcare.

Health disparities are causing serious harm, leading to 400 amputations per day

Interventional cardiologist Foluso Fakorede, MD, says everything from limited specialists to a lack of sidewalks are causing a disproportionate rate of minorities to be caught in the current PAD and CLI epidemic.

Interview with Nehal Mehta, MD, Penn Medicine, who explains how coronary inflammation can be seen using AI on cardiac CT scans to better risk stratify patients and begin preventive drug therapy.

AI helps cardiologists track new drug's effect on inflammation

The combination of AI and CT helped Nehal Mehta, MD, and colleagues track the performance of a new drug designed to target coronary inflammation. 

Jeff Kuvin, MD, explains the effort to create an new independent cardiology board. He is the ACC point person for the effort.

The push for an independent cardiology board continues

Jeffrey Kuvin, MD, one of the leading voices behind efforts to create a new Board of Cardiovascular Medicine, spoke with Cardiovascular Business about where things stand today.

doctor examines patient data on their tablet

Moderate aortic stenosis linked to heightened risk of death—should TAVR, surgery be considered?

Researchers tracked data from more than 400,000 patients for a new meta-analysis, presenting their findings in the Journal of the American Heart Association.

Hēlo PE Thrombectomy System developed by U.S. medical device company Endovascular Engineering

Dual-action thrombectomy device could give cardiologists a new tool for treating acute PE

The new device is believed to be the first of its kind, using both aspiration and mechanical clot disruption to remove blood clots.